Corrigendum to "A tumor cell membrane-coated self-amplified nanosystem as a nanovaccine to boost the therapeutic effect of anti-PD-L1 antibody" [Bioact. Mater. 21 299-312
机构：[1]Laboratory of Stem Cell Biology, Department of Radiology, Huaxi MR Research Centner (HMRRC), Department of Biotherapy, Cancer Center, National Clinical Research Center for Geriatrics, Frontiers Science Center for Disease-related Molecular Network, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, 610041, China.四川大学华西医院[2]Functional and Molecular Imaging Key Laboratory of Sichuan Province, Research Unit of Psychoradiology, Chinese Academy of Medical Sciences, Chengdu, 610041, China.[3]Amgen Bioprocessing Centre, Keck Graduate Institute, Claremont, CA, 91711, USA.
第一作者机构：[1]Laboratory of Stem Cell Biology, Department of Radiology, Huaxi MR Research Centner (HMRRC), Department of Biotherapy, Cancer Center, National Clinical Research Center for Geriatrics, Frontiers Science Center for Disease-related Molecular Network, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, 610041, China.
推荐引用方式(GB/T 7714)：
Li Zhilin,Cai Hao,Li Zhiqian,et al.Corrigendum to "A tumor cell membrane-coated self-amplified nanosystem as a nanovaccine to boost the therapeutic effect of anti-PD-L1 antibody" [Bioact. Mater. 21 299-312[J].Bioactive materials.2023,22:74.doi:10.1016/j.bioactmat.2022.09.016.
APA：
Li Zhilin,Cai Hao,Li Zhiqian,Ren Long,Ma Xuelei...&Luo Kui.(2023).Corrigendum to "A tumor cell membrane-coated self-amplified nanosystem as a nanovaccine to boost the therapeutic effect of anti-PD-L1 antibody" [Bioact. Mater. 21 299-312.Bioactive materials,22,
MLA：
Li Zhilin,et al."Corrigendum to "A tumor cell membrane-coated self-amplified nanosystem as a nanovaccine to boost the therapeutic effect of anti-PD-L1 antibody" [Bioact. Mater. 21 299-312".Bioactive materials 22.(2023):74
医学